Fig. 3
Correlation between serum sclerostin levels and CBM scores in r-axSpA with fatty lesions. The serum sclerostin levels correlated negatively with CBM scores (ρ = -0.920, p < 0.001)
Fig. 3 | Arthritis Research & Therapy
Correlation between serum sclerostin levels and CBM scores in r-axSpA with fatty lesions. The serum sclerostin levels correlated negatively with CBM scores (ρ = -0.920, p < 0.001)